We are Merck : a vibrant Science and Technology company Created by Friedrich Jacob in 1668 at Darmstadt (Germany). Since we laid our cornerstone more than 350 years ago, we have become truly global and are present in France for more than 50 years.
Every day, our more than 64,000 employees work in 66 countries to make a positive difference to millions of people’s lives by creating more joyful and sustainable ways to live.
Our 3 business sectors are : Healthcare, Life Science and Electronics.
In our Life Science business, we empower the scientific community by providing scientists lab materials, technologies and services to make research and biotech production simpler, faster, and safer.
A company with tradition and future
MACHEREY-NAGEL was founded in 1911 in Düren as a specialist manufacturer of filter papers. Since that time, we have evolved into an innovative international company for chemical and biomolecular analysis.
Family-owned in the 4th generation.
More than 700 employees.
5 sites in Düren.
Subsidiaries in Germany, Switzerland, France and the U.S.
Worldwide sales in 150 countries.
More than 25,000 products.
MACHEREY-NAGEL stands for innovative and creative solutions which we have a penchant for developing in-house. In addition to the “traditional” departments, such as research, production, sales and media design, we also have departments such as mechanical engineering and device development as well as our own joinery.
Our products are among the world’s most reliable analytical systems. They are used, for example, in industry, healthcare, biotechnology, environmental analysis and research. Numerous patents and international certifications underscore the high quality of our products and the competence of our employees
Major breakthroughs in sciences often result from combining
interdisciplinary approaches and development of new technologies.
Scientific research increasingly relies on new technologies, turning out
to be more and more challenging to be implemented. Identifying expert
scientists able to adapt novel technologies and up-to date core
facilities is of increasing importance to conceive and implement
innovative and competitive projects. For example, the emergence in the
early 2000’s of “next generation sequencing” technologies boosted the
rise of technological core facilities and directly contributed to the
development of genomics.
Biogenouest was initiated in 2002 as a Scientific Interest Group and is
now joining together 12 members: Universities and institutes in higher
education and/or research established in Western France, i.e. Régions
Bretagne and Pays de la Loire. Today, this network joins together 38
core facilities, organized in 6 technological areas: genomics,
proteomics, bioinformatics, functional exploration, bioimaging,
structural and metabolomic analysis. They cover 4 research fields:
marine science, agriculture and food science, human health, and data
science.
By joining together resources and relevant skills, Biogenouest aims to
facilitate and promote access to cutting-edge technologies to a broad
scientific community, delivering hands-on solutions and innovation to
public and private research laboratories in life and environmental
sciences. Biogenouest also contributes to optimize and coordinate
financial supports, allowing core facilities to provide cut-edging
technology and facilitating innovative developments. These core
facilities share knowledge, provide concerted and coordinated services,
and propose training sessions. Most core facilities are also part of
national or European research infrastructures, reflecting their
expertise and leading roles in their scientific domains.
Biogenouest is supported by its members, by the Régions Bretagne and
Pays de la Loire, and by IBiSA.
"La Ligue Nationale contre le Cancer" (French League against cancer) is a public interest association founded in 1918 after WWI, when cancer was recognized to be a spreading epidemic. The League's goal is to help cancer patients, their family and friends. Since its founding, the League has developed into a strong network and leads the fight against cancer on three levels; research, promotion of screening and prevention, and care for patients and their loved ones. The League is a federation of 103 departmental committees that are active in relaying the mission of the administrative council and the national scientific council. The League has more than 720,000 members, 30,000 volunteers and 300 salaried staff who keep the network active by leading the fight and generating the essential resources of the league. "La Ligue Nationale contre le Cancer" became a full UICC member in 1968.
At the IGDR, our primary focus is on cell and developmental biology, and genetics. We emphasize two main scientific axes: Genomic Biology and Cancer (GBC) with 6 teams, and Cell Biology, Cell Development, Biophysics (CCB) with 9 teams. These axes are interconnected, reflecting our commitment to understanding life's dynamics. We've established "Observing Life" as a third transversal theme to integrate these areas.
The GBC teams study genetic materials and alterations, primarily through nucleic acid analysis and (deoxy)ribonucleoprotein complex studies. The CCB teams focus on observing cellular and multicellular organisms. By combining these approaches, we can identify cellular and organismal consequences of genetic alterations, providing insights into human pathologies. Our recent expansion includes the recruitment of two new teams, supported by newly acquired laboratory space.
The University of Rennes is an experimental public institution. Open to Europe and the world, at the heart of the Brittany Region and linked to Rennes Métropole and its ecosystem, it is built on a common history and the strengths of its founding members. It has one ambition: to meet the major societal challenges of a world in transition, particularly in the fields of the environment, global health and digital technology.
The National Centre for Scientific Research (CNRS) is a major player in basic research on the global stage and the only organisation in France that is active in all fields of science. Its unique position as a specialist in multiple fields means that it can bring together different scientific disciplines to shed light on and gain insight into current global challenges, in partnership with public sector, social and economic stakeholders. Together the sciences are used to bring about sustainable progress that benefits the whole of society.
Rennes Métropole is the intercommunal structure centred on the city of Rennes. It is located in the Ille-et-Vilaine department, in the Brittany region, western France.
It aims to build a better metropolitan area by synchronizing the transport system, environmental actions, urbanization, economic and social development, culture, university research, etc.
Founded in 1964, Inserm is a public scientific and technological institute which operates under the joint authority of the French Ministries of Health and Research. The institute is dedicated to biomedical research and human health, and is involved in the entire range of activities from the laboratory to the patient’s bedside. It also partners with the most prestigious research institutions in the world that are committed to scientific challenges and progress in these fields.